ÂÜÀòÂÒÂ×

Matthew joined iTeos from Sarepta Therapeutics, Inc. in June 2020 where he was the Senior Vice President of Corporate Development and Treasurer and where he led the Company’s recent partnering process with Roche, resulting in a multibillion dollar collaboration agreement and raised over $2billion from capital markets. During his 15 year career in biotech financial management and corporate development, Matthew also worked at Celgene and Gilead Sciences. Matthew has an MBA from the University of Chicago Booth School of Business.